Introduction: According to the Global TB Report 2022 [1], the COVID-19 pandemic significantly impacted TB services in both high and…
ABSTRACT Even if major improvements in therapeutic regimens and treatment outcomes have been progressively achieved, tuberculosis (TB) remains the leading…
BACKGROUND: Treatment outcomes in multidrug-resistant TB (MDR-TB) patients are suboptimal in several low-incidence countries. METHODS: The primary outcome measure was…
A cura di Flavia Chechi, medico in formazione specialistica in Malattie infettive e tropicali Insieme ad altri 17 giovani colleghi…
Introduction Tuberculosis (TB) represents one of the major global health concerns, with 10 million new cases estimated in 2022 and…
Dear Editor, It is estimated that about a quarter of the global population is infected with Mycobacterium tuberculosis and TB…
Abstract Background Human migration and the ever-changing geopolitical scenarios are redefining the epidemiology and the management of tuberculosis (TB), especially…
ABSTRACT One of the most challenging issues with the sources of ancient medicine is to be able to identify the…
Dear Editor, We read with interest the article ‘Treatment out- comes and safety of bedaquiline, delamanid, and line- zolid in…
Abstract: Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the…
Dear Editor, In recent years, many aspects of TB management have dramatically changed due to increasing evidence- based data, new…
Trattamento su misura per la tubercolosi negli individui transgender: un appello per un approccio centrato sul paziente da una grande…
Nome:
Cognome:
Indirizzo e-mail :
Privacy e trattamento dei dati personali Accetto privacy
